Lgt Group Foundation Amgen Inc Transaction History

Lgt Group Foundation

$6.53 Billion
Q2 2024

A detailed history of Lgt Group Foundation transactions in Amgen Inc stock. As of the latest transaction made, Lgt Group Foundation holds 23,145 shares of AMGN stock, worth $7.46 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

23,145

Previous 6,320 266.22%

Holding current value

$7.46 Million

Previous $1.8 Million 302.62%

% of portfolio

0.11%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $4.42 Million - $5.37 Million	16,825 Added 266.22%	23,145 $7.23 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $91,684 - $110,674	341 Added 5.7%	6,320 $1.8 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $368,719 - $415,959	-1,442 Reduced 19.43%	5,979 $1.72 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $149,993 - $186,221	686 Added 10.19%	7,421 $1.99 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $1.34 Million - $1.59 Million	-6,273 Reduced 48.22%	6,735 $1.5 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $723,205 - $881,465	-3,203 Reduced 19.76%	13,008 $3.14 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $1.8 Million - $2.29 Million	-7,865 Reduced 32.67%	16,211 $4.26 Million
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $8.62 Million - $9.72 Million	-38,390 Reduced 61.46%	24,076 $5.43 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $3.32 Million - $3.69 Million	-14,385 Reduced 18.72%	62,466 $15.2 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $3.8 Million - $4.21 Million	-17,339 Reduced 18.41%	76,851 $18.7 Million
Q4 2021 May 03, 2022	BUY	$198.88 - $227.6 $18.7 Million - $21.4 Million	94,190 New	94,190 $21.2 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.

Account

Lgt Group Foundation Amgen Inc Transaction History